ABVX: Abivax Pharma Sotuvga nisbatan narx
ABIVAX yallig'lanishga qarshi vositalarning muvaffaqiyatli sinovlari orqali tan olinayotgan ambitsiyali biotexnologiya ishlab chiquvchisidir. Biroq, savdoning yo'qligi va cheklangan kapital kompaniyani yakuniy sinovlar natijalariga nisbatan zaif qiladi. Klinikalar va tadqiqot markazlari bilan hamkorlik orqali o'sish tezlashmoqda. Kompaniyaning normallashtirilgan P/S ko'rsatkichi talab va daromad o'rtasidagi muvozanatni baholashga yordam beradi, bunda darajasi aktivning joriy holatini aks ettiradi.
Abivax Pharma (ABVX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati koeffitsiyenti ABIVAX|ABVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Abivax Corp|ABVX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Abivax Pharma|ABVX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi Abivax|Tezkor likvidlik koeffitsiyenti abivax.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ABVX - Sof foyda|Kutilayotgan foyda ABIVAX|ABVX - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati Abivax|ABVX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Abivax Pharma|ABVX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Abivax|ABVX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi abivax.com|ABVX - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi ABIVAX
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:ABVX abivax.com
P/S koeffitsienti bozor kapitalizatsiyasining yillik daromadga nisbati sifatida hisoblanadi va aktivning haddan tashqari qimmat baholanganligini aniqlash uchun sotuvlarning har bir rublining tannarxini belgilaydi. ABIVAX (ABVX) uchun bozor P/S koeffitsienti obefazimodning tijorat muvaffaqiyatiga bo'lgan bozor kutganlarini aks ettiradi, bunda joriy biznes baholash bevosita klinik sinovlar natijalariga va Big Pharma bilan hamkorlik istiqbollariga bog'liqdir.
ABIVAX kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|ADMA Biologics Inc (ADMA) - Sotuvga nisbatan narx|Protagonist Therapeutics Inc - P/S multiplikatori|IMVT - P/S multiplikatori|KNSA: P/S multiplikatori|GRFS (grifols.com) - Narxning daromadga nisbati|ADPT (Adaptive Biotechnologies Corporation) - P/S multiplikatori|Celldex Therapeutics Inc (CLDX) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati AUPH (Aurinia Pharma)|Narxning daromadga nisbati BCRX (BioCryst Corp)|P/S multiplikatori VERA (Vera Therapeutics, Inc.)|P/S multiplikatori dianthustx.com DNTH|PHVS: Kapitalizatsiyaning daromadga nisbati|ABCL (AbCellera Biologics Inc.) - Kapitalizatsiya va daromad nisbati|TRML: P/S multiplikatori|Precigen Corp (PGEN) - P/S multiplikatori|PHAR (Pharming Group N.V.) - P/S multiplikatori|Narxning daromadga nisbati NKTR|Kapitalizatsiyaning daromadga nisbati UPB (Upstream Bio)|Narxning daromadga nisbati ZBIO (Zenas Bio)|Immunome Corp - Kapitalizatsiyaning daromadga nisbati|GOSS: Kapitalizatsiya va daromad nisbati|KALV - Narxning daromadga nisbati|Narxning sotuvga nisbati SEPN|PVLA: P/S multiplikatori|Savara Inc - Bozor kapitallashuvining daromadga nisbati|RIGL (Rigel Pharmaceuticals Inc) - P/S multiplikatori|P/S multiplikatori AnaptysBio Inc.|Narxning daromadga nisbati Astria Therapeutics (ATXS)|ENGN (engene.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati RAPT Therapeutics RAPT|JBIO - Kapitalizatsiyaning daromadga nisbati|Aclaris - P/S multiplikatori|KYTX - P/S multiplikatori|TLSA (Tiziana Life Sciences) - Kapitalizatsiyaning daromadga nisbati|cabalettabio.com - Bozor kapitallashuvining daromadga nisbati|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|Theratechnologies, Inc. (THTX) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Avalo Therapeutics Inc. (AVTX)|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals, Inc ELDN|Narxning daromadga nisbati Agenus AGEN|CLYM - Kapitalizatsiyaning daromadga nisbati|ZURA: Kapitalizatsiyaning daromadga nisbati|ATYR - P/S multiplikatori|adagene.com (ADAG) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati IMA|STTK (Shattuck Labs Inc) - P/S multiplikatori|Sotuvga nisbatan narx Equillium Bio EQ|P/S multiplikatori CNTB|P/S multiplikatori immunic-therapeutics.com (IMUX)|P/S multiplikatori ATRA (Atara Bio)|InflaRx NV - Narxning daromadga nisbati|X4 Pharmaceuticals - P/S multiplikatori|Narx/daromad koeffitsiyenti Adicet Bio ACET|CELU (celularity.com) - Kapitalizatsiyaning daromadga nisbati|INMB (INmune Bio Inc) - Narxning daromadga nisbati|BRNS (Barinthus Bio) - P/S multiplikatori|P/S multiplikatori Kezar Life Sciences Inc|Kapitalizatsiyaning daromadga nisbati SABS (SAB Biotherapeutics)|akaritx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|P/S multiplikatori Q32 Bio Inc QTTB|GeoVax Labs Inc - P/S multiplikatori|EDSA: Narxning daromadga nisbati|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|CARM (Carisma Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiya va daromad nisbati BOLT (Bolt Bio)|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|APVO: Narxning sotuvga nisbati|P/S multiplikatori AIM (AIM ImmunoTech Inc.)|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio - P/S multiplikatori|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Revelation Biosciences Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiyaning daromadga nisbati scinai.com (SCNI)|P/S multiplikatori CALI|P/S multiplikatori affimed.com (AFMD)|Allakos - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati HOOK|IGM Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti iteostherapeutics.com ITOS|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati TC BioPharm (Holdings) Plc|Narxning daromadga nisbati Third Harmonic Bio, Inc
